2-Phenyl-1,2-dihydro-3H-pyrazol-3-one hydrochloride, 97%, 250mg

3,3-Difluoro-1-(methylaminomethyl)cyclobutanol, 98%, 250mg

4-Boc-4,7-diazaspiro[2.5]octane, 95.0%, 250mg

Powder funnel, 50 mm, 10 Piece(s)

HPLC column NUCLEODUR® 100-5 C18 ec 5 µm, 250 mm, 4.6 mm, 1 Piece(s)

1-(2-Amino-3-bromo-4-methoxyphenyl)ethanone, 95.0%, 5g

(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, 98.0%, 250mg

2-chloro-5-(1H-1,2,3,4-tetrazol-5-yl)pyridine, 98%, 1g

1-Butyl-3-methylimidazolium Tricyanomethanide>98.0%(HPLC)(N)5g

2-Allyl-1-[6-(1-hydroxy-1-methylethyl)pyridin-2-yl]-6-[[4-(4-methylpiperazin-1-yl)phenyl]amino]-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one, 98%, 250mg

PCR individual vials Mμlti®, blue, 200 µl 1000 pcs

2,4,5,6-Tetrachloropyrimidine, 96.0%, 500g

Methyl azetidine-2-carboxylate hydrochloride, 95.0%, 500mg